North America Contract Research Organisation (CRO) Services Market Report and Forecast 2024-2032
CRO services are pivotal in aiding the pharmaceutical, biotechnological, and medical device industries in the enhancement of their research and development (R&D) activities. These organisations primarily offer services such as clinical trial management, data analysis, and regulatory consultancy, thereby playing an indispensable role in expediting drug development processes and enhancing overall healthcare outcomes.
The augmentation in pharmaceutical research and development and the spiralling investments in biotechnology are the key drivers propelling the North America contract research organisation (CRO) services market growth. With the intensification of chronic diseases and the escalating demand for innovative therapeutic solutions, pharmaceutical and biotech companies are progressively leaning towards CROs to mitigate operational costs and fast-track drug development timelines.
The rising complexity of clinical trials and the increasing regulatory scrutiny in the pharmaceutical sector necessitate the augmentation of specialised knowledge and advanced solutions, thus accentuating the indispensability of CRO services in North America. The upsurge in novel therapeutic modalities and the burgeoning requirement for precision medicine are further bolstering the demand for CRO services, enabling companies to navigate through the intricate web of regulatory frameworks and clinical developments.
The North America contract research organisation (CRO) services market demand is also fuelled by the advancements in biotechnological research and the burgeoning need for specialised knowledge in areas such as genomics and proteomics. The emergent wave of biotherapeutics and the rising prominence of personalised medicine are accelerating the need for CROs, allowing companies to access cutting-edge technologies and specialised expertise.
According to the North America contract research organisation (CRO) services market analysis, the increasing focus on patient-centric approaches and the rising incorporation of real-world evidence in clinical trials are enhancing the scope of CRO services in the region. With patient well-being gaining prominence, there is an increasing emphasis on optimising clinical trial designs and ensuring the stringent adherence to ethical standards and regulatory compliances.
Market Outlook
According to the report the North America contract research organisation (CRO) services market grew significantly in 2023. Aided by the burgeoning demand in pharmaceutical and biotechnological sectors and the escalating need for specialised services, the market is projected to further grow at a CAGR of 7.70% between 2024 and 2032 to reach a value of about USD 45.5 billion by 2032.CRO services are pivotal in aiding the pharmaceutical, biotechnological, and medical device industries in the enhancement of their research and development (R&D) activities. These organisations primarily offer services such as clinical trial management, data analysis, and regulatory consultancy, thereby playing an indispensable role in expediting drug development processes and enhancing overall healthcare outcomes.
The augmentation in pharmaceutical research and development and the spiralling investments in biotechnology are the key drivers propelling the North America contract research organisation (CRO) services market growth. With the intensification of chronic diseases and the escalating demand for innovative therapeutic solutions, pharmaceutical and biotech companies are progressively leaning towards CROs to mitigate operational costs and fast-track drug development timelines.
The rising complexity of clinical trials and the increasing regulatory scrutiny in the pharmaceutical sector necessitate the augmentation of specialised knowledge and advanced solutions, thus accentuating the indispensability of CRO services in North America. The upsurge in novel therapeutic modalities and the burgeoning requirement for precision medicine are further bolstering the demand for CRO services, enabling companies to navigate through the intricate web of regulatory frameworks and clinical developments.
The North America contract research organisation (CRO) services market demand is also fuelled by the advancements in biotechnological research and the burgeoning need for specialised knowledge in areas such as genomics and proteomics. The emergent wave of biotherapeutics and the rising prominence of personalised medicine are accelerating the need for CROs, allowing companies to access cutting-edge technologies and specialised expertise.
According to the North America contract research organisation (CRO) services market analysis, the increasing focus on patient-centric approaches and the rising incorporation of real-world evidence in clinical trials are enhancing the scope of CRO services in the region. With patient well-being gaining prominence, there is an increasing emphasis on optimising clinical trial designs and ensuring the stringent adherence to ethical standards and regulatory compliances.
Market Segmentation
The market can be divided based on service type, therapeutic area, end use, and region.Market Breakup by Service Type
- Early Phase Development Services
- Discovery Science
- Chemistry
- Preclinical Services
- Clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Laboratory Services
- Analytical Testing Services
- Bioanalytical Testing Services
- Others
Market Breakup by Therapeutic Area
- Oncology
- Clinical Pharmacology
- Cardiovascular
- Infectious Disease
- Neurology
- Gastroenterology and Hepatology
- Respiratory
- Others
Market Breakup by End Use
- Pharmaceutical and Biopharmaceutical Companies
- Medical Device Companies
- Academic Institutes
- Others
Market Breakup by Region
- United States
- Canada
Competitive Landscape
The report looks into the market shares, plant turnarounds, capacities, investments, and mergers and acquisitions, among other major developments, of the leading companies operating in the North America contract research organisation (CRO) services market. Some of the major players explored in the report are as follows:- IQVIA Holdings Inc.
- Thermo Fisher Scientific Inc.
- Medpace Holdings, Inc.
- Parexel International Corporation
- Labcorp
- Clinipace
- ICON plc
- Medpace, Inc
- Others
Table of Contents
1 Preface2 Report Coverage - Key Segmentation and Scope4 Key Assumptions6 Market Snapshot7 Opportunities and Challenges in the Market12 Key Trends and Developments in the Market10. North America Contract Research Organisation (CRO) Services Market Structure
3 Report Description
5 Executive Summary
8 North America Contract Research Organisation (CRO) Services Market Analysis
9 Regional Analysis
10 Market Dynamics
11 Competitive Landscape
List of Key Figures and Tables
Companies Mentioned
- IQVIA Holdings Inc.
- Thermo Fisher Scientific Inc. Medpace Holdings Inc.
- Parexel International Corporation
- Labcorp
- Clinipace
- ICON plc
- Medpace Inc
Methodology
LOADING...
